Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities
Authors:
- 15 March 2017
- journal article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 70 (5) , 562-567
Abstract
Screening for circumventors of β-lactam resistance in methicillin-resistant Staphylococcus aureus (MRSA) led us to find 17 novel antibiotics, naphthacemycins A1-A11, B1-B4 and C1-C2. The naphthacemycins were isolated from a cultured broth of Streptomyces sp. KB-3346-5 by repeated silica gel column chromatography and HPLC. Naphthacemycins enhanced imipenem activity 100-500 times against MRSA at 0.5 μg ml-1, and naphthacemycins A4-A11 themselves showed MIC50 values of 1-4 μg ml-1 against 22 MRSA strains.Keywords
This publication has 19 references indexed in Scilit:
- Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. II. Structure elucidationThe Journal of Antibiotics, 2017
- Tetarimycin A, an MRSA-Active Antibiotic Identified through Induced Expression of Environmental DNA Gene ClustersJournal of the American Chemical Society, 2012
- Environmental DNA-Encoded Antibiotics Fasamycins A and B Inhibit FabF in Type II Fatty Acid BiosynthesisJournal of the American Chemical Society, 2012
- Biverlactones A–D, new circumventors of arbekacin resistance in MRSA, produced by Penicillium sp. FKI-4429Tetrahedron, 2011
- Functional analysis of environmental DNA-derived type II polyketide synthases reveals structurally diverse secondary metabolitesProceedings of the National Academy of Sciences, 2011
- The tetracycline resistomeCellular and Molecular Life Sciences, 2009
- The role of virulence determinants in community-associated MRSA pathogenesisTrends in Microbiology, 2008
- Cyslabdan, a New Potentiator of Imipenem Activity against Methicillin-resistant Staphylococcus aureus, Produced by Streptomyces sp. K04-0144The Journal of Antibiotics, 2008
- Cyslabdan, a New Potentiator of Imipenem Activity against Methicillin-resistant Staphylococcus aureus, Produced by Streptomyces sp. K04-0144The Journal of Antibiotics, 2008
- Tetracycline analogs whose primary target is not the bacterial ribosomeAntimicrobial Agents and Chemotherapy, 1994